Laboratoires Fournier Sa

Laboratories Fournier S.a.

Laboratoire Fournier

Véronique Barberousse

Michel Bondoux

Didier Thomas

Vincent Peyrou

Soth Samreth

Benaïssa Boubia

François Bellamy

The invention relates to novel 5-thioxylose compounds, preferably derivatives of the 5-thioxylopyranose type, to the process for their preparation and to their use as active principles of drugs intended especially for the treatment or prevention of thrombosis or cardiac insufficiency.

Compounds derived from 5-thioxylose and their use in therapeutics

The invention relates to new compounds of 5-thioxilose, preferably derivatives of the 5-thioxilopyranose type, and to a method for preparing the same and their use as the active ingredient of drugs mainly intended for treating or inhibiting thrombosis or heart failure or thromboembolic diseases.

Derivatives of 5-thioxylopyranose and use of same for treatment

Compounds of 5-thioxylopyranose, preferably derivatives of the 5-thioxilopyranose type, a method for preparing such compounds, and the use of such compounds as an active ingredient in pharmaceutical compositions which are useful, in particular, for treating or inhibiting thrombosis or heart failure or thromboembolic disease states.

5-thioxylopyranose compounds

5-thioxylose compounds, especially 5-thioxylopyranose compounds, a process for their preparation, and their use for treating and/or inhibiting thromboses, especially venous thromboses. The compounds correspond to formula I: in which the pentapyranosyl group represents a free or substituted 5-thio-&#x3b2;-D-xylopyranosyl group; R', R&#x2033; and R&#x2032;&#x2033; each independently represent a hydrogen atom, a C-Cacyl group, or two adjacent ones of them form a 1-methylethylidene bridge; Xand Xeach represent carbon or nitrogen; Yand Yeach independently represent carbon, nitrogen, sulfur or oxygen, with the proviso that if Yrepresents oxygen or sulfur, then Yrepresents carbon or nitrogen; R, R, R, Rand Reach independently represent hydrogen, a COORgroup where Rrepresents hydrogen or a C-Calkyl group optionally substituted by a phenyl ring, a halogen atom or a &#x2014;COORgroup; a C-Calkoxy group; a C-Cacyl group; a benzoyl group or a phenyl ring; and the addition salts and/or active metabolites of such compounds.

5-Thioxylopyranose compounds

The invention relates to novel 5-thioxylose compounds, preferably derivatives of the 5-thioxylopyranose type, to the method for their preparation and to their use as active principles of drugs intended especially for the treatment or prevention of thromboses or cardiac insufficiency.

Thioxylose compounds, preparation method thereof, pharmaceutical compositions containing same and use thereof in therapeutics

The present invention relates to novel compounds of formula (I):in which: These compounds are useful particularly for the treatment of disorders of the venous circulation.

Growing community of inventors

Hauteville-les-Dijon, France

Véronique Barberousse